V Olume 51 • Issue 2 • a Ugust 2021

Total Page:16

File Type:pdf, Size:1020Kb

V Olume 51 • Issue 2 • a Ugust 2021 Web ofIndexed Science in Original Articles Anti-proliferative effects of indomethacin, acemetacin and their tromethamine salts in HCT116 human colon cancer cells Gökçe Cihan Üstündağ, Berna Somuncu, Meltem Müftüoğlu, Nilgün Karalı In vitro assessment of cytotoxic, apoptotic and genotoxic effects of metformin Tuba Sarıaydın, Tuğbagül Çal, Sevtap Aydın Dilsiz, Hande Canpınar, Ülkü Ündeğer Bucurgat Nickel oxide nanoparticles induced DNA damages in human liver cells Mahmoud Abudayyak, E. Elif Güzel, Gül Özhan Effects of chlorpyrifos-methyl, chlormequat, deltamethrin, glyphosate, pirimiphos-methyl, tebuconazole and their mixture on oxidative stress and toxicity in HUVEC cell line Çiğdem Sevim, Ali Taghizadehghalehjoughi, Mehtap Kara The effects of prochloraz on the levels of nuclear receptor genes expressions and global DNA methylation in human prostate carcinoma cells Ecem Fatma Karaman, Esma Doğan, Dilara Alga, Sibel Özden Cytotoxicity and DNA protective effects of the Terfezia and Picoa species from the eastern region of Turkey Mehmet Akyüz, Işık Didem Karagöz, Şule İnci, İbrahim Halil Kılıç, Sevda Kırbağ, Başak Simitçioğlu Central possible antinociceptive mechanism of naringin Mehmet Evren Okur, Çinel Köksal Karayıldırım Anti-fertility and antisteroidogenic activity of Clerodendrum serratum in mature male rats Navaneetha Krishnan Subramaniyan, Nagarajan Govinda Rajan, Karthikeyan Elumalai, Sathyanathan Viswanathan, Jayaraman Rajangam, Preeti Gutha, Sivaneswari Srinivasan Curcumin prevents tenofovir/lamivudine/efavirenz-induced nephrotoxicity in rats Elias Adikwu, Ruth O. Owota, Innocent Biradee Phytochemical profiling of the bioactive principles ofAlysicarpus glumaceus (Vahl) DC. aerial parts Ferhat Khan, Mohammed Garba Magaji, Ibrahim Abdu-Aguye, Isa Marte Hussaini, Asmau Hamza, Amina Busola Olorukooba, Yahaya Muhammad Sani, Muneer Ari Sani, Idris Muhammad Maje Quantitative determinations on commercial samples of Melissae folium and their antioxidant activity Ayşegül Karadeniz, Buket Bozkurt, Gülen İrem Kaya Evaluation of herbal medicine use in the obstetric and gynecology department Yunus Emre Ayhan, Emine Akalın Exploring the effects of individual innovativeness dimensions on performance: a study with pharmaceutical managers Nilay Tarhan, Sevgi Şar Short Paper The preliminary ethnobotanical survey of medicinal plants in Develi (Kayseri/Turkey) Zeynep Büşra Erarslan, Rıdvan Çolak, Şükran Kültür Review Articles VOLUME 51 • ISSUE 2 • AUGUST 2021 51 • ISSUE 2 AUGUST VOLUME Examining the basic principles of quality by design (QbD) approach in analytical studies Burcu Mesut, Cem Önal, Buket Aksu, Yıldız Özsoy The role of compaction simulator equipment in formulation design Yıldız Özalp, Nailla Jiwa Histone deacetylase inhibitors providing an epigenetic treatment in cancer Tuğçe Cinek, Nilgün Karalı ijp.istanbul.edu.tr EISSN 2587-2087 INDEXING AND ABSTRACTING Web of Science - Emerging Sources Citation Index (ESCI) TÜBİTAK-ULAKBİM TR Index CAS Database A-I OWNER Prof. Dr. Erdal CEVHER İstanbul University, Faculty of Pharmacy, Department of Pharmaceutical Technology, İstanbul, Turkey RESPONSIBLE MANAGER Asst. Prof. Bahar GÜRDAL ABAMOR İstanbul University, Faculty of Pharmacy, Department of Pharmaceutical Botany, İstanbul, Turkey CORRESPONDENCE ADDRESS İstanbul University, Faculty of Pharmacy, Department of Pharmaceutical Botany, Beyazıt, 34116, Fatih / İstanbul, Turkey Phone: +90 212 440 02 75 Fax: +90 212 440 02 52 E-mail: [email protected] https://dergipark.org.tr/tr/pub/iujp https://iupress.istanbul.edu.tr/tr/journal/ijp/home PUBLISHER İstanbul University Press İstanbul University Central Campus, 34452 Beyazit, Fatih / İstanbul, Turkey Phone: +90 212 440 00 00 Authors bear responsibility for the content of their published articles. The publication languages of the journal is English. This is a scholarly, international, peer-reviewed and open-access journal published triannually in April, August and December. Publication Type: Periodical A-II EDITORIAL MANAGEMENT BOARD Editor-in-Chief Prof. Dr. Emine AKALIN İstanbul University, Faculty of Pharmacy, Department of Pharmaceutical Botany, İstanbul, Turkey – [email protected] Co-Editors-in-Chief Prof. Dr. B. Sönmez UYDEŞ DOĞAN İstanbul University, Faculty of Pharmacy, Department of Pharmacology, İstanbul, Turkey – [email protected] Prof. Dr. Nilgün KARALI İstanbul University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, İstanbul, Turkey – [email protected] Section Editors Prof. Dr. Nuriye AKEV İstanbul University, Faculty of Pharmacy, Department of Biochemistry, İstanbul, Turkey – [email protected] Prof. Dr. Nilgün KARALI İstanbul University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, İstanbul, Turkey – [email protected] Prof. Dr. B. Sönmez UYDEŞ DOĞAN İstanbul University, Faculty of Pharmacy, Department of Pharmacology, İstanbul, Turkey – [email protected] Prof. Dr. Sevgi GÜNGÖR İstanbul University, Faculty of Pharmacy, Department of Pharmaceutical Technology, İstanbul, Turkey – [email protected] Asst. Prof. Bahar GÜRDAL ABAMOR İstanbul University, Faculty of Pharmacy, Department of Pharmaceutical Botany, İstanbul, Turkey – [email protected] Language Editors Elizabeth Mary EARL Istanbul University, Department of Foreign Languages, Istanbul, Turkey – [email protected] Alan James NEWSON Istanbul University, Department of Foreign Languages, Istanbul, Turkey – [email protected] Statistics Editor Prof. Dr. Abdülbari BENER İstanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, Department of Biostatistics and Medical Informatics, İstanbul, Turkey – [email protected] Scientific Secretariat Asst. Prof. Gülsev ÖZEN İstanbul University Faculty of Pharmacy, Department of Pharmacology, İstanbul, Turkey – [email protected] A-III EDITORIAL BOARD Afife MAT İstanbul University, Faculty of Pharmacy, Department of Pharmacognosy, İstanbul, Turkey – [email protected] Berna ÖZBEK-ÇELİK İstanbul University, Faculty of Pharmacy, Department of Pharmaceutical Microbiology, İstanbul, Turkey – [email protected] Bilge ŞENER Gazi University, Faculty of Pharmacy, Department of Pharmacognosy, Ankara, Turkey – [email protected] Carsten EHRHARDT Trinity College Dublin, School of Pharmacy and Pharmaceutical Sciences and Trinity Biomedical Sciences Institute, Dublin, Ireland – [email protected] Claudiu T. SUPURAN University of Florence, Section of Pharmaceutical and Nutriceutical Sciences, Neurofarba Department, Florence, Italy – [email protected] Domenico Vittorio DELFINO University of Perugia, Department of Medicine and Surgery, Perugia, Italy – [email protected] Erden BANOĞLU Gazi University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Ankara, Turkey – [email protected] Fatma AKAR Gazi University, Faculty of Pharmacy, Department of Pharmacology, Ankara, Turkey – [email protected] Gianniantonio DOMINA University of Palermo, Food and Forest Sciences, Department of Agricultural, Palermo, Italy – [email protected] İlkay KÜÇÜKGÜZEL Marmara University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, İstanbul, Turkey – [email protected] Johan Van de VOORDE Ghent University, Department of Pharmacology, Gent, Belgium – [email protected] Melih ALTAN Bezmialem University, Faculty of Pharmacy, Department of Pharmacology, İstanbul, Turkey – [email protected] Meral ÖZALP Hacettepe University, Faculty of Pharmacy, Department of Pharmaceutical Microbiology, Ankara, Turkey – [email protected] Müberra KOŞAR Eastern Mediterranean University, Faculty of Pharmacy, Department of Pharmacognosy, Famagusta, Northern Cyprus – [email protected] Nilüfer YÜKSEL Ankara University, Faculty of Pharmacy, Department of Pharmaceutical Technology, Ankara, Turkey – [email protected] Nurşen BAŞARAN Hacettepe University, Faculty of Pharmacy, Department of Pharmaceutical Toxicology, Ankara, Turkey – [email protected] Oya ALPAR Altınbaş University, Faculty of Pharmacy, Department of Pharmaceutical Technology, İstanbul, Turkey and Department of Pharmaceutical Technology, UCL, UK – [email protected] Özlem Nazan ERDOĞAN İstanbul University, Faculty of Pharmacy, Department of Pharmacy Management, İstanbul, Turkey – [email protected] Sıdıka TOKER İstanbul University, Faculty of Pharmacy, Department of Analytical Chemistry, İstanbul, Turkey – [email protected] Sibel ÖZDEN İstanbul University, Faculty of Pharmacy, Department of Pharmaceutical Toxicology, İstanbul, Turkey – [email protected] Stephen R. DOWNIE University of Illinois, Department of Plant Biology, Urbana, Illinois, USA – [email protected] Tao CHEN Medical College of Soochow University, School of Public Health, Department of Toxicology, Suzhou, China – [email protected] Ufuk KOLAK İstanbul University, Faculty of Pharmacy, Department of Analytical Chemistry, İstanbul, Turkey – [email protected] Zeliha YAZICI Biruni University, Faculty of Medicine, Department of Medical Pharmacology, İstanbul, Turkey – [email protected] A-IV INSTRUCTIONS TO AUTHORS AIMS AND SCOPE İstanbul Journal of Pharmacy is currently indexed in Web of Science-Emerging Sources Citation Index, TU- İstanbul Journal of Pharmacy (Istanbul J Pharm) is an BITAK ULAKBIM TR Index and CAS database. international, scientific, open access periodical pub- lished in accordance with independent, unbiased, and Processing and publication
Recommended publications
  • Forest Farming
    Forest Farming Ken Mudge CY ROSE N NA Many sections of the Northeast have been reforested over the past century. Extensive forest cover is seen in this view from Wachu- sett Mountain in central Massachusetts. armers harvest crops from their fields, and agroforestry—a multidisciplinary approach to loggers harvest trees from their forests, agricultural production that achieves diverse, Fbut what do forest farmers harvest? The profitable, sustainable land use by integrating answer is an eclectic collection of non-timber trees with non-timber forest crops. forest crops like maple syrup, medicinal herbs, While some other agroforestry practices begin fruits, gourmet mushrooms, and nuts. with planting young trees that take years to Forest farming is an approach to forest man- mature, forest farming involves planting non- agement that combines some of the manage- timber forest crops beneath the canopy of an ment practices of conventional forestry with established forest. In other words, other agro- those of farming or gardening to achieve forestry practices bring the forest to the crops, an environmentally and economically sus- whereas forest farming brings the crops to the tainable land-use system. It is one of several forest. In this regard it is helpful to consider related practices that fall under the domain of the role of forest farming in overall forest man- Forest Farming 27 agement. A forest farm should be designed to bearing trees including walnuts and peaches, emulate as much as possible a natural forest. but there is no evidence of deliberate culti- This includes characteristics of a healthy forest vation of useful crops beneath the canopy of ecosystem such as species diversity, resilience established forest.
    [Show full text]
  • Priscila-IAEA
    1 SM/EB-13 E-beam Irradiation of “in nature” Palm: Texture and Color Evaluation Silva, P.V a; Nunes, T.C.F a; Furgeri a, C.; Pitombo b, R.N.M; Hojeije c, K.Y. and Villavicencio, A.L.C.H a a Instituto de Pesquisas Energéticas e Nucleares (IPEN/CNEN-SP), Centro de Tecnologia das Radiações, Laboratório de Detecção de alimentos Irradiados, Cidade Universitária, Av. Professor Lineu Prestes 2242, Butantã CEP 05508-000 São Paulo - SP, Brazil. b Faculdade Ciências Farmacêuticas, Departamento de Tecnologia Farmacêutica e Bioquímica, Universidade de São Paulo, Av. Professor Lineu Prestes 580, Bloco 16 CEP 05508-900 São Paulo – SP, Brazil. c Floresta Indústria e Comércio Ltda. Rodovia Régis Bittencourt BR116, Km 416 Bairro Piúva CEP 118000- 000. Juquiá , São Paulo-SP, Brazil. Email contact of main author: [email protected] [email protected] Abstract The palm tree ( Bactris gasipaes Kunth) is a potential raised species with economic, for the nutritional value of its fruits that can in such way be used in the feeding human being as in the animal, and mainly, for the extraction of the palm that currently has a bigger interest in this culture. Food irradiation is a worldwide technology that aims to improve the product quality, in order to eliminate diverse microorganisms that can spoil the food. Irradiation processing, in the recommended doses, causes very few chemical alterations in foods, nutritional losses are considered insignificant and some of the alterations known found in irradiated foods is not harmful or dangerous. The objective of this work was to evaluate physical characteristics of in nature peach palm, such as color and texture, after combination of e-beam processing and refrigeration.
    [Show full text]
  • SCH 58261: a Potent and Selective Non-Xanthine A2A Adenosine Receptor Antagonist
    22 DIRECTED DRUG DISCOVERY™ LIGAND-SETS™ for Assay Validation and High Throughput Screening Easy-to-use collections of pharmacologically-similar, small organic ligands Sigma-RBI LIGAND-SETS™ are a convenient and affordable way to screen a specific target with a collection of well- characterized, pharmacologically-active compounds. Each LIGAND-SET™ contains 40-80 high purity (>96%), small organic ligands arranged by pharmacological class in a 96-well format, one compound (2 mg) per well (1 ml capacity). N Standardize/validate new screening assays with well-characterized ligands N Guide secondary screening of larger, diverse libraries using pharmaceutically-relevant structures N Screen new drug targets for leads with pharmacologically-active compounds Nine different LIGAND-SETS™ are now available: N Adrenergics (Prod. No. L 0383) N Enzyme Inhibitors (Prod. No. L 6787) N Purines/Pyrimidines (Prod. No. L 2538) N Cholinergics (Prod. No. L 2663) N GABAergics (Prod. No. L 7884) N Glutamatergics (Prod. No. L 6537) N Dopaminergics (Prod. No. L 6412) N Ion Channel Modulators (Prod. No. L 6912) N Serotonergics (Prod. No. L 6662) For further information, please visit our Drug Discovery website at sigma-aldrich.com/drugdiscovery Technical information for each compound is provided in standard SD file format for use with ISIS/Base or other compatible software (software not provided). SCH 58261: A potent and selective non-xanthine A2A adenosine receptor antagonist Vol. 19 No. 4 Vol. Adenosine (Prod. No. A 9251) acts as a modulator of [3]. These results suggest a neuroprotective effect of this neuronal activity through its interaction with four receptor compound. In another study, the role of A1 and A2A subtypes referred to as A1, A2A, A2B and A3.
    [Show full text]
  • Effect of Theophylline and Enprofylline on Bronchial Hyperresponsiveness
    Thorax: first published as 10.1136/thx.44.12.1022 on 1 December 1989. Downloaded from Thorax 1989;44:1022-1026 Effect of theophylline and enprofylline on bronchial hyperresponsiveness G H KOETER, J KRAAN, M BOORSMA, J H G JONKMAN, TH W VAN DER MARK From the Department ofPulmonology and Lung Function, University Hospital, Groningen; Pharma Bio Research, Assen; and Astra Pharmaceutica, Rijswijk, The Netherlands ABSTRACT The effect of increasing intravenous doses of theophylline and enprofylline, a new xanthine derivative, on bronchial responsiveness to methacholine was studied in eight asthmatic patients. Methacholine provocations were carried out on three days before and after increasing doses of theophylline, enprofylline, and placebo, a double blind study design being used. Methacholine responsiveness was determined as the provocative concentration of methacholine causing a fall of 20% in FEV, (PC20). The patients were characterised pharmacokinetically before the main study to provide an individual dosage scheme for each patient that would provide rapid steady state plasma concentration plateaus of 5, 10, and 15 mg/l for theophylline and 1 25, 2 5, and 3-75 mg/l for enprofylline. Dose increments in the main study were given at 90 minute intervals. FEV, showed a small progressive decrease after placebo; it remained high in relation to placebo after both drugs and this effect was dose related. Methacholine PC20 values decreased after placebo; mean values were (maximum difference 2-0 and 1 7 higher after theophylline and enprofylline than after placebo copyright. doubling doses of methacholine); the effect of both drugs was dose related. Thus enprofylline and theophylline when given intravenously cause a small dose related increase in FEV1 and methacholine PC20 when compared with placebo.
    [Show full text]
  • Pro-Aging Effects of Xanthine Oxidoreductase Products
    antioxidants Review Pro-Aging Effects of Xanthine Oxidoreductase Products , , Maria Giulia Battelli y , Massimo Bortolotti y , Andrea Bolognesi * z and Letizia Polito * z Department of Experimental, Diagnostic and Specialty Medicine-DIMES, Alma Mater Studiorum, University of Bologna, Via San Giacomo 14, 40126 Bologna, Italy; [email protected] (M.G.B.); [email protected] (M.B.) * Correspondence: [email protected] (A.B.); [email protected] (L.P.); Tel.: +39-051-20-9-4707 (A.B.); +39-051-20-9-4729 (L.P.) These authors contributed equally. y Co-last authors. z Received: 22 July 2020; Accepted: 4 September 2020; Published: 8 September 2020 Abstract: The senescence process is the result of a series of factors that start from the genetic constitution interacting with epigenetic modifications induced by endogenous and environmental causes and that lead to a progressive deterioration at the cellular and functional levels. One of the main causes of aging is oxidative stress deriving from the imbalance between the production of reactive oxygen (ROS) and nitrogen (RNS) species and their scavenging through antioxidants. Xanthine oxidoreductase (XOR) activities produce uric acid, as well as reactive oxygen and nitrogen species, which all may be relevant to such equilibrium. This review analyzes XOR activity through in vitro experiments, animal studies and clinical reports, which highlight the pro-aging effects of XOR products. However, XOR activity contributes to a regular level of ROS and RNS, which appears essential for the proper functioning of many physiological pathways. This discourages the use of therapies with XOR inhibitors, unless symptomatic hyperuricemia is present.
    [Show full text]
  • Effect of Ganoderma Lucidum (Reishi) on Hematological Parameters
    Available online at www.ijmrhs.com cal R edi ese M ar of c l h a & n r H u e o a J l l t h International Journal of Medical Research & a S n ISSN No: 2319-5886 o c i t i Health Sciences, 2018, 7(3): 151-157 e a n n c r e e t s n I • • IJ M R H S Effect of Ganoderma lucidum (Reishi) on Hematological Parameters in Wistar Rats Hammad Ahmed and Muhammad Aslam* Department of Pharmacology, Faculty of Pharmacy, Ziauddin University, Karachi, Pakistan *Corresponding e-mail: [email protected] ABSTRACT Ganoderma lucidum (Reishi), has been used in Traditional Chinese Medicine (TCM) for 5000 years or more. In China and Japan Ganoderma lucidum has been used in folk medicine, commonly in the treatment of neurasthenia, insomnia, hepatopathy, nephritis, gastric ulcers, asthma, and hypertension. In this study we have evaluated the effect of Ganoderma lucidum on hematological parameters in Wistar rats. The extract was given orally by gavage at the dose of 150 mg/kg and 300 mg/kg body weight. The result of our study shows extremely significant increase in the hemoglobin level, platelet count and leukocyte count more specifically at a dose of 150 mg/kg of Ganoderma lucidum extract when compare with normal control group. However, at a dose of 300 mg/kg of GLE, significant increase in hemoglobin level and extremely significant increase in leukocyte count were observed. Whereas, insignificant result was observed at both the doses of GLE in case of hematocrit level, MCV, MCHC, MCH and RBC count.
    [Show full text]
  • COPD Agents Review – October 2020 Page 2 | Proprietary Information
    COPD Agents Therapeutic Class Review (TCR) October 1, 2020 No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, digital scanning, or via any information storage or retrieval system without the express written consent of Magellan Rx Management. All requests for permission should be mailed to: Magellan Rx Management Attention: Legal Department 6950 Columbia Gateway Drive Columbia, Maryland 21046 The materials contained herein represent the opinions of the collective authors and editors and should not be construed to be the official representation of any professional organization or group, any state Pharmacy and Therapeutics committee, any state Medicaid Agency, or any other clinical committee. This material is not intended to be relied upon as medical advice for specific medical cases and nothing contained herein should be relied upon by any patient, medical professional or layperson seeking information about a specific course of treatment for a specific medical condition. All readers of this material are responsible for independently obtaining medical advice and guidance from their own physician and/or other medical professional in regard to the best course of treatment for their specific medical condition. This publication, inclusive of all forms contained herein, is intended to be educational in nature and is intended to be used for informational purposes only. Send comments and suggestions to [email protected]. October 2020
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 8,603,526 B2 Tygesen Et Al
    USOO8603526B2 (12) United States Patent (10) Patent No.: US 8,603,526 B2 Tygesen et al. (45) Date of Patent: Dec. 10, 2013 (54) PHARMACEUTICAL COMPOSITIONS 2008. O152595 A1 6/2008 Emigh et al. RESISTANT TO ABUSE 2008. O166407 A1 7/2008 Shalaby et al. 2008/0299.199 A1 12/2008 Bar-Shalom et al. 2008/0311205 A1 12/2008 Habib et al. (75) Inventors: Peter Holm Tygesen, Smoerum (DK); 2009/0022790 A1 1/2009 Flath et al. Jan Martin Oevergaard, Frederikssund 2010/0203129 A1 8/2010 Andersen et al. (DK); Karsten Lindhardt, Haslev (DK); 2010/0204259 A1 8/2010 Tygesen et al. Louise Inoka Lyhne-versen, Gentofte 2010/0239667 A1 9/2010 Hemmingsen et al. (DK); Martin Rex Olsen, Holbaek 2010, O291205 A1 11/2010 Downie et al. (DK); Anne-Mette Haahr, Birkeroed 2011 O159100 A1 6/2011 Andersen et al. (DK); Jacob Aas Hoellund-Jensen, FOREIGN PATENT DOCUMENTS Frederikssund (DK); Pemille Kristine Hoeyrup Hemmingsen, Bagsvaerd DE 20 2006 014131 1, 2007 (DK) EP O435,726 8, 1991 EP O493513 7, 1992 EP O406315 11, 1992 (73) Assignee: Egalet Ltd., London (GB) EP 1213014 6, 2002 WO WO 89,09066 10, 1989 (*) Notice: Subject to any disclaimer, the term of this WO WO91,040 15 4f1991 patent is extended or adjusted under 35 WO WO95/22962 8, 1995 U.S.C. 154(b) by 489 days. WO WO99,51208 10, 1999 WO WOOOf 41704 T 2000 WO WO 03/024426 3, 2003 (21) Appl. No.: 12/701,429 WO WOO3,O24429 3, 2003 WO WOO3,O24430 3, 2003 (22) Filed: Feb.
    [Show full text]
  • Oxidative Stress and Parkinson's Disease: New Hopes in Treatment with Herbal Antioxidants
    See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/283728452 Oxidative stress and Parkinson's disease: New hopes in treatment with herbal antioxidants Article in Current pharmaceutical design · November 2015 CITATIONS READS 43 1,053 4 authors, including: Mahmoud Bahmani Hedayatollah Shirzad 219 PUBLICATIONS 2,021 CITATIONS Shahrekord University of Medical Sciences 106 PUBLICATIONS 1,357 CITATIONS SEE PROFILE SEE PROFILE Mahmoud Rafieian-kopaei Shahrekord University of Medical Sciences 337 PUBLICATIONS 5,110 CITATIONS SEE PROFILE Some of the authors of this publication are also working on these related projects: Genetic mapping of deafness in Iran View project expression of anti-oxidative stress genes in ulcerative colitis View project All content following this page was uploaded by Mahmoud Bahmani on 28 November 2015. provided by shahrekord university of medical scinces The user has requested enhancement of the downloaded file. View metadata, citation and similar papers at core.ac.uk CORE brought to you by Send Orders for Reprints to [email protected] Current Pharmaceutical Design, 2016, 22, 000-000 1 Oxidative Stress and Parkinson’s Disease: New Hopes in Treatment with Herbal Antioxidants Amir Sarrafchi1, Mahmoud Bahmani2, Hedayatollah Shirzad1 and Mahmoud Rafieian-Kopaei1* 1Medical Plants Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran; 2Food and Bev- erages Safety Research Center, Urmia University of Medical Sciences, Urmia, Iran Abstract: Parkinson's disease (PD) is a neurodegenerative disorder due to dopamine deficit in substatia nigra. PD is mainly a sporadic disease with unestablished etiology. However, exposure to environmental toxins, head trauma, Please provide corresponding author(s) inflammation, and free radicals are potential reasons.
    [Show full text]
  • Role of Oxidative Stress and Neuroinflammation in Attention
    antioxidants Review Role of Oxidative Stress and Neuroinflammation in Attention-Deficit/Hyperactivity Disorder Juan Carlos Corona Laboratory of Neurosciences, Hospital Infantil de México Federico Gómez, Mexico City 06720, Mexico; [email protected]; Tel.: +52-55-5228-9917 Received: 27 July 2020; Accepted: 8 September 2020; Published: 23 October 2020 Abstract: Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder of childhood. Although abnormalities in several brain regions and disturbances of the catecholaminergic pathway have been demonstrated, the pathophysiology of ADHD is not completely understood, but as a multifactorial disorder, has been associated with an increase in oxidative stress and neuroinflammation. This review presents an overview of factors that increase oxidative stress and neuroinflammation. The imbalance between oxidants and antioxidants and also the treatment with medications are two factors that can increase oxidative damage, whereas the comorbidity between ADHD and inflammatory disorders, altered immune response, genetic and environmental associations, and polymorphisms in inflammatory-related genes can increase neuroinflammation. Evidence of an association with these factors has become valuable for research on ADHD. Such evidence opens up new intervention routes for the use of natural products as antioxidants that could have potential as a treatment against oxidative stress and neuroinflammation in ADHD. Keywords: oxidative stress; neuroinflammation; attention-deficit/hyperactivity disorder
    [Show full text]
  • Combining Herbs and Essential Oils This Presentation Explores How
    Hawthorn University Holistic Health and Nutrition Webinar Series 2017 www.hawthornuniversity.org Presented by David Crow, L.Ac. Combining Herbs and Essential Oils This presentation explores how essential oils and aromatherapy can be integrated with herbal treatments for added therapeutic effects and benefits. It explores which essential oils can be safely combined, and how, with herbs according to therapeutic functions: ) Expectorant, mucolytic, decongestant and antitussive herbs ) Nervine relaxant, sedative and anxiolytic herbs ) Demulcent herbs ) Anti-spasmotic and analgesic herbs ) Antimicrobial herbs ) Cholagogue and laxative herbs ) Immune modulating and immune stimulating herbs ) Adaptogen, trophorestorative and neuroendocrine regulating herbs ) Antiinflammatory herbs ) Emmenagogue and uterine tonic herbs Learning Objectives: ) When and how essential oils and aromatherapy are a primary, adjunct or contraindicated treatment ) To understand the compatibility or lack of compatibility of specific groups and species of essential oils and specific groups and species of herbs ) Simple combinations of herbs and essential oils for specific therapeutic benefits Introduction ) General suggestions for how to use safely therapeutic groups of essential oils in combinations with groups of herbs. ) Does not give detailed methods of use of the oils. ) Does not give any specific dosages or uses of herbs. ) Please do not use herbs without studying them in detail. ) Please use essential oils according to safe methods of applications ) Do not take internally ) Do not apply undiluted to the skin Difficulties classifying essential oils into therapeutic categories Where do the claims about therapeutic actions of essential oils come from? 1. Empirical evidence from long history of use of aromatic plants 2. Modern scientific studies 3. Claims made about essential oils through MLM companies and spread on the internet Many claims about the functions of essential oils are not substantiated or established.
    [Show full text]
  • The Worm Turns: Earthworm Cast Reduction on Golf Courses
    research research thrive under the conditions required to maintain mid-1990s were applied for grub control but were healthythrive under turfgrass the conditionsand are so required adaptable to maintainthat cul- alsomid-1990s acutely were toxic applied to earthworms for grub (14).control Most but of were the turalhealthy manipulations turfgrass and alone are soare adaptableunlikely tothat resolve cul- olderalso acutely worm-toxic toxic topesticides earthworms can no (14). longer Most be of used the castingtural manipulations problems. Physical alone are removal unlikely of tocasts resolve by onolder turf, worm-toxic and presently pesticides no pesticides can no longerare labeled be used for brushing,casting problems. switching Physical or dragging removal is laborious of casts and by earthwormon turf, and control presently in theno pesticidesUnited States. are labeled for Theofbrushing, only temporary switching worm benefit or dragging (8). is laborious turns: and earthworm control in the United States. of only temporary benefit (8). Peter Lees’ invention Chemical control PeterAn approach Lees’ inventionwidely used used for earthworm earthwormChemicalDuring control the past 20 years the problem of exces-castandAn cast approach suppression reduction widely from used the used early for 20th earthworm century siveDuring earthworm the past castings 20 years interfering the problem with of play exces- on untiland cast about suppression 1960 involved from the the early use 20thof chemical century ongolfsive earthwormcourses, golf sport castings
    [Show full text]